Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

Isavuconazole (ISAV) is a novel water-soluble triazole with potential advantages over existing agents. In a cohort of patients with cryptococcosis and endemic mycoses ISAV was well tolerated, exhibited a favorable safety profile, and demonstrated clinical activity against these endemic fungi.

Bibliographic Details
Main Authors: Thompson, George R., Rendon, Adrian, Ribeiro dos Santos, Rodrigo, Queiroz-Telles, Flavio, Ostrosky-Zeichner, Luis, Azie, Nkechi, Maher, Rochelle, Lee, Misun, Kovanda, Laura, Engelhardt, Marc, Vazquez, Jose A., Cornely, Oliver A., Perfect, John R.
Format: Online
Language:English
Published: Oxford University Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946023/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946023/

Similar Items